Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatotic Liver Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06735924
What this trial is testing

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Who this might be right for
MASLDMetabolic Dysfunction-Associated Steatotic Liver Disease
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Study completedNCT04555434
What this trial is testing

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Chuncheon Sacred Heart Hospital 89
Not applicableUnknownNCT04154696
What this trial is testing

APHP Plateform of Normothermic Perfusion for Rehabilitation of Hepatic Grafts

Who this might be right for
Liver Diseases
Assistance Publique - Hôpitaux de Paris 20
Not applicableNot Yet RecruitingNCT07716995
What this trial is testing

Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaMetabolic Dysfunction-Associated Steatotic Liver Disease
Assiut University 127
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableActive Not RecruitingNCT07172997
What this trial is testing

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Who this might be right for
MASLDT2DM (Type 2 Diabetes Mellitus)Non-alcoholic Fatty Liver Disease (NAFLD)+1 more
Royal College of Surgeons in Ireland - Medical University of Bahrain 163
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableUnknownNCT06328452
What this trial is testing

Risk Factors and Impact MASLD in Patients With IBD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Assiut University 120
Not applicableLooking for participantsNCT07122700
What this trial is testing

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more
Foundation for the National Institutes of Health 400
Testing effectiveness (Phase 2)Study completedNCT06140953
What this trial is testing

Benefits of Trimetazidine in MASLD Patients

Who this might be right for
Metabolic Associated Fatty Liver Disease
October 6 University 60
Not applicableLooking for participantsNCT07378072
What this trial is testing

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital 72
Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Not applicableNot Yet RecruitingNCT07636915
What this trial is testing

Association Between Fatty Liver and Inflammatory Biomarkers

Who this might be right for
Fatty Liver
Sohag University 100
Not applicableUnknownNCT06490432
What this trial is testing

Pattern of Cardiac Arrhythmia in Patients With MASLD

Who this might be right for
Cardiac ArrhythmiaMetabolic Dysfunction Associated Steatotic Liver Disease
Sohag University 100
Not applicableNot Yet RecruitingNCT07781371
What this trial is testing

A Retrospective Real-World Cohort Study

Who this might be right for
ObesityType 2 Diabetes (T2D)Prediabetes+4 more
Novo Nordisk A/S 100,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableStudy completedNCT07798518
What this trial is testing

FIB-4 Index, Sleep Apnea Severity, and Nocturnal Hypoxemia

Who this might be right for
Obstructive Sleep Apnea (OSA)Metabolic Dysfunction-Associated Steatotic Liver Disease
Hisar Intercontinental Hospital 373
Not applicableLooking for participantsNCT06984510
What this trial is testing

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Metabolic Dysfunction-Associated Steatotic Liver DiseaseBiological Age
Ningbo No. 1 Hospital 2,720
Not applicableStudy completedNCT06121999
What this trial is testing

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)Metabolic Associated-dysfunction Steatohepatitis (MASH)
Grand Valley State University 24
Next Page
114